Escitalopram versus other antidepressive agents for major depressive disorder: a systematic review and meta-analysis

Escitalopram versus other antidepressive agents for major depressive disorder: a systematic review and meta-analysis

Abstract Background Escitalopram is selective serotonin reuptake inhibitors (SSRIs) and one of the most commonly prescribed newer antidepressants (ADs) worldwide. We aimed to explore the efficacy, acceptability and tolerability of escitalopram in comparison with other ADs in the acute-phase treatmen...

Full description

Bibliographic Details
Main Authors: Juntao Yin, Xiaoyong Song, Chaoyang Wang, Xuhong Lin, Mingsan Miao
Format: Article
Language:English
Published: BMC 2023-11-01
Series:BMC Psychiatry
Subjects:
Escitalopram
Antidepressant
Selective serotonin reuptake inhibitors (SSRI)
Major depressive disorder (MDD)
Meta-analysis
Online Access:https://doi.org/10.1186/s12888-023-05382-8

Internet

https://doi.org/10.1186/s12888-023-05382-8

Similar Items